science
plus
.abes.fr
|
explorer
À propos de :
Liver: Infectious, Inflammatory, and Metabolic Disorders
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
skos:Concept
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Concept
New Facet based on Instances of this Class
Attributs
Valeurs
type
Concept
rdfs:label
Liver: Infectious, Inflammatory, and Metabolic Disorders
Liver: Infectious, Inflammatory, And Metabolic Disorders
skos:inScheme
http://hub.abes.fr/referentiel/springer/periodical/10620/articletypes
is
article type
of
Development of granulomatous hepatitis during treatment with interferon-α2b
Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis
Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang)
Evaluation of quantitative assay for antibody to hepatitis C virus core in patients treated with interferon
Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis
Serum levels of soluble interleukin-2 receptors and effects of interferon-α for patients with chronic hepatitis C virus
IL-1β and TNF-α produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C
Primary biliary cirrhosis induced by interferon-α therapy for hepatitis C virus infection
Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon
Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection
A lectin histochemical study of intrahepatic ducts in patients with hepatolithiasis
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome
Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B
Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis
Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B
Occurrence of antibody against rat hepatic sinusoidal endothelial cells in sera of patients with autoimmune hepatitis
Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon
Effect ofS-adenosyl-l-methionine on ethanol cholestasis and hepatotoxicity in isolated perfused rat liver
Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C
Treatment of symptomatic hepatic cysts by percutaneous instillation of minocycline hydrochloride
Hepatic expression of interferon-α in chronic hepatitis B virus infection
Serum levels of interferon-α and-γ in acute and chronic hepatitis B virus infection
[13C]Aminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives
Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C
Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy
Tuberculous peritonitis complicating corticosteroid therapy for acute alcoholic hepatitis
Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver
Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases
First-pass metabolism of alcohol
α-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C
Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-α
High-dose interferon-α2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C
Interferon-α2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection
Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay
Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis
IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C
Nucleotide sequence analysis of the precore region in patients with spontaneous reactivation of chronic hepatitis B
Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy
Chemotactic factors released from hepatocytes exposed to acetaminophen
Validation of scoring system for diagnosis of autoimmune hepatitis
Non-HLA-linked hemochromatosis in a Chinese woman
Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg
Hepatic fas antigen expression before and after interferon therapy in patients with chronic hepatitis C
Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutinin-induced proliferation and interleukin-2 production of human lymphocytes
Nonalcoholic steatohepatitis
Nafcillin-associated hepatotoxicity
Hepatic stimulator substance administration enhances regenerative capacity of hepatocytes in cadmium-pretreated partially hepatectomized rats
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
